Equities
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)700.00
  • Today's Change0.00 / 0.00%
  • Shares traded827.00
  • 1 Year change+7.69%
  • Beta--
Data delayed at least 20 minutes, as of Nov 29 2022 12:17 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Tuesday, 4Basebio PLC (4BB:LSE) closed at 700.00, -5.30% below its 52-week high of 739.20, set on Nov 29, 2022.
52-week range
Today
390.00Jul 12 2022739.20Nov 29 2022
Markit short selling activity
Low
Med
High
Open700.00
High730.00
Low730.00
Bid650.00
Offer750.00
Previous close700.00
Average volume3.40k
Shares outstanding12.32m
Free float4.65m
P/E (TTM)--
Market cap86.22m GBP
EPS (TTM)-0.326
GBP
Data delayed at least 20 minutes, as of Nov 29 2022 12:17 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.